Treace Medical Concepts, Inc. TMCI
Set alert
As of Nov 2, 10:45 AM ET
- YTD
- +88.11%
- 1 year
- -27.88%
- Open
- 4.45
- Prev close
- 4.43
- Mkt cap
- 302.41M
- Vol
- 45.96K
- Avg vol
- 285.23K
- EPS
- -0.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.45
- High
- 4.80
- Forward P/E
- -9.28
- Beta
- 0.24
- Short ratio
- 3.26
- Inst. own
- 64.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 6.87
- 200-d avg
- 7.45
- 1y target
- 7.96
News
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 59.2% to $1.99 during Wednesday's pre-market session. Lipocine (NASDAQ:LPCN) shares rose 52.38% to $3.2. The company's market cap…
-
1 month ago benzinga.com
Treace Medical Presents 5-Year ALIGN3D Data Showing 0.8% Recurrence Rate Alongside MTA3D And SPRINT Clinical Results At AOFAS 2026
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and other foot & ankle
-
2 months ago benzinga.com
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $4 to $5.
-
2 months ago benzinga.com
Treace Medical Concepts Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $45.376M Beat $44.020M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) by 20 percent. This is a 14.29 percent increase over losses…
-
2 months ago benzinga.com
Treace Medical Concepts Raises FY2026 Sales Guidance from $202.000M-$212.000M to $204.000M-$212.000M vs $206.220M Est
Treace Medical Concepts (NASDAQ:TMCI) raises FY2026 sales outlook from $202.000 million-$212.000 million to $204.000 million-$212.000 million vs $206.220 million estimate.
-
3 months ago benzinga.com
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $2 to $4.
-
4 months ago benzinga.com
Treace Medical Concepts Announces Completion Of First Case Utilizing Its HyperPlate XM Dynamic Compression Locking Implant, Complete Commercialization Expected in Q3 of 2026
HyperPlate™ fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the titanium compression implants to deliver rapid insertion and…
-
5 months ago benzinga.com
Treace Medical Concepts Raises FY2026 Sales Guidance from $200.000M-$212.000M to $202.000M-$212.000M vs $205.920M Est
Treace Medical Concepts (NASDAQ:TMCI) raises FY2026 sales outlook from $200.000 million-$212.000 million to $202.000 million-$212.000 million vs $205.920 million estimate.
-
5 months ago benzinga.com
Treace Medical Concepts Q1 EPS $(0.28) Beats $(0.31) Estimate, Sales $47.198M Beat $45.960M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 12 percent decrease over losses of…
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
6 months ago benzinga.com
US Stocks Mixed; Dow Falls Over 100 Points
US stocks mixed; Dow falls 0.29% as inflation rate surges to 3.3%. Materials up 0.8%, financials down 0.8%. Asian markets close higher.
-
8 months ago benzinga.com
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7
Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $7.5 to $7.
-
8 months ago benzinga.com
Treace Medical Concepts Sees FY2026 Sales $200.000M-$212.000M vs $210.335M Est
2026 Financial OutlookThe Company is initiating full-year 2026 revenue guidance of $200 million to $212 million representing a decline of 6% to 0% compared to full-year 2025.The Company expects a…
8 months ago benzinga.com
Treace Medical Concepts Q4 Earnings Summary & Key Takeaways
Treace Medical Concepts Q4 Earnings Summary & Key Takeaways
-
8 months ago benzinga.com
Treace Medical Concepts Q4 EPS $(0.15), Inline, Sales $62.519M Beat $61.390M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 1400 percent decrease over losses of $(0.01) per share from…
8 months ago benzinga.com
Earnings Scheduled For February 27, 2026
Earnings Scheduled For February 27, 2026
8 months ago benzinga.com
Treace Medical Concepts's Earnings: A Preview
Treace Medical Concepts's Earnings: A Preview
-
9 months ago benzinga.com
Treace Medical Concepts Completes First Case Utilizing Its Lapiplasty Lightning Technology
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot…
-
9 months ago benzinga.com
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts
-
9 months ago benzinga.com
Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3
Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $5 to $3.
-
10 months ago benzinga.com
Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $4 to $3.
-
10 months ago benzinga.com
Treace Medical Enters Into New Five Year $175M Senior Secured Loan Arrangement With Credit Funds Managed By SLR Capital Partners
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities,…
-
11 months ago benzinga.com
Truist Securities Reiterates Hold on Treace Medical Concepts, Lowers Price Target to $4
Truist Securities analyst Richard Newitter reiterates Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $7 to $4.
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
11 months ago benzinga.com
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November
-
11 months ago benzinga.com
UBS Maintains Neutral on Treace Medical Concepts, Lowers Price Target to $5.85
UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target from $6.5 to $5.85.
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
12 months ago benzinga.com
JP Morgan Downgrades Treace Medical Concepts to Underweight, Lowers Price Target to $5
JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutral to Underweight and lowers the price target from $8 to $5.
-
12 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 months ago benzinga.com
Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Block Posts Downbeat Q3 Results, Joins Archer Aviation, DraftKings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
-
12 months ago benzinga.com
Treace Medical Concepts Lowers FY2025 Sales Guidance from $224.000M-$230.000M to $211.000M-$213.000M vs $227.083M Est
Treace Medical Concepts (NASDAQ:TMCI) lowers FY2025 sales outlook from $224.000 million-$230.000 million to $211.000 million-$213.000 million vs $227.083 million estimate.
-
12 months ago benzinga.com
Treace Medical Concepts Q3 EPS $(0.26) Beats $(0.28) Estimate, Sales $50.214M Beat $49.732M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 4 percent decrease over losses of…
12 months ago benzinga.com
Earnings Scheduled For November 6, 2025
Earnings Scheduled For November 6, 2025
-
1 year ago benzinga.com
Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $7
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $8 to $7.
-
1 year ago benzinga.com
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $8
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $6.6 to $8.
-
1 year ago benzinga.com
UBS Maintains Neutral on Treace Medical Concepts, Lowers Price Target to $6.5
UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target from $8.6 to $6.5.
-
1 year ago benzinga.com
Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $6
Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $9 to $6.
-
1 year ago benzinga.com
Treace Medical Concepts Affirms FY2025 Sales Guidance of $224.000M-$230.000M vs $227.030M Est
Treace Medical Concepts (NASDAQ:TMCI) affirms FY2025 sales outlook from $224.000 million-$230.000 million to $224.000 million-$230.000 million vs $227.030 million estimate.
-
1 year ago benzinga.com
Treace Medical Concepts Q2 EPS $(0.28) Beats $(0.29) Estimate, Sales $47.387M Beat $47.077M Estimate
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.29) by 2.78 percent. This is a 17.65 percent increase over losses…
-
1 year ago benzinga.com
Treace Medical Concepts Announces Peer-Reviewed Publication Of The 4-Year Interim Results From Its ALIGN3D Multicenter Prospective Study Demonstrating Clinical And Radiographic Outcomes Of The Lapiplasty Procedure In The Journal Of Foot & Ankle Surgery
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities,…
-
1 year ago benzinga.com
Treace Medical Concepts Files Patent Infringement Lawsuit Against Zimmer Biomet And Paragon 28, Alleging Violation Of 4 Patents Related To Its Lapiplasty 3D Bunion Correction Technologies And Seeking Injunctive Relief And Damages
Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities…
-
1 year ago benzinga.com
Earnings Scheduled For February 27, 2025
Earnings Scheduled For February 27, 2025
1 year ago benzinga.com
Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Why Pinterest Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
1 year ago benzinga.com
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
-
1 year ago benzinga.com
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session